Apposite Capital Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Apposite Capital has acquired 2 companies.

Apposite Capital’s most common sectors for investment arehealthcare services (43%) and medical products (16%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (53%) and growth capital (27%). In total, Apposite Capital has invested in 1 US state and 7 different countries.

The Firm’s most common exit type is trade sale (100%). Apposite Capital’s largest (disclosed) exit occurred in 2013 when it sold ZONARE Medical Systems for $102M.

Subscribe to Mergr to view Apposite Capital’s full profile and discover more small private equity firm investors just like it.

M&A Summary

  • M&A Total Activity26
    • M&A Buy Activity19
    • M&A Sell Activity7
  • Total Sectors Invested 8
  • Total Countries Invested 7
  • M&A Buy/Sell Connections 10
  • M&A Advisors 15

Apposite Capital

Apposite Capital LLP

21 Whitefriars Street,
London, EC4Y 8JJ
United Kingdom
+44(0)20 3475 1710
www.appositecapital.com
enquiry@appositecapital.com

Apposite Capital is a private investment firm focused on investing in growth companies in the healthcare sector. The Firm targets UK-based, revenue generating businesses and looks to invest £10 to £25 million over the life of an investment. Specific areas of interest include rehab services, primary and acute care companies, health related software solutions and IT, elderly and specialist healthcare services, medical products, and pharmaceuticals. Apposite Capital was established in 2006 and is based in London.


Investment Criteria

Sectors of Interest: Business Services, Consumer Services, Education, Healthcare Services, Information Services, Information Technology, Internet Software and Services, Life Science, Medical Products, Software

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Growth Capital, Venture

Geographic Preferences: United Kingdom, Western Europe

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 10 25
Enterprise Value - -
values in millions of GBP

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (1.6/yr) # 11 6 1 - 1 - 19
Sell (0.2/yr) # 6 1 - - - - 7
vol $169M $169M
  26

Most Recent M&A

Company Date Value Type
Octavia House Schools 2024-01-01 - Buyout (LBO, MBO, MBI)
London, United Kingdom · www.ohs.uk
Kelso Pharma 2022-01-14 - Consolidation
Kelso, United Kingdom · www.kelsopharma.com
HCML 2021-11-15 - Buyout (LBO, MBO, MBI)
London, United Kingdom · www.hcml.co.uk
CrestOptics S.p.A. 2021-11-11 - Buyout (LBO, MBO, MBI)
Rome, Italy · www.crestoptics.com
i2a Diagnostics 2021-08-02 - Buyout (LBO, MBO, MBI)
Montpellier, France · www.i2a-diagnostics.fr
1MED SA 2021-05-25 - Buyout (LBO, MBO, MBI)
Agno, Switzerland · www.1med.ch
Emblation Ltd. 2021-05-24 - Growth Capital
Alloa, United Kingdom · www.emblation.com
MiHomecare Ltd. 2021-03-01 - Trade Sale
Nottingham, United Kingdom · www.mihomecare.com
Habitus 2021-01-01 - Buyout (LBO, MBO, MBI)
Brondby, Denmark · www.habitus.dk
Mirada Medical Ltd. 2019-04-08 - Growth Capital
Oxford, United Kingdom · www.mirada-medical.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 4 (29%) - 8 (42%) -
Medical Products 3 (21%) - 3 (16%) -
Business Services 1 (7%) - 2 (11%) -
Consumer Services 2 (14%) - 2 (11%) -
Education 1 (7%) - 1 (5%) -
Life Science 1 (7%) - 1 (5%) -
Machinery 1 (7%) - 1 (5%) -
Software 1 (7%) - 1 (5%) -
Total 14 - 19 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United Kingdom 9 (64%) - 13 (68%) -
France 1 (7%) - 1 (5%) -
Spain 1 (7%) - 1 (5%) -
Italy 1 (7%) - 1 (5%) -
Denmark 1 (7%) - 1 (5%) -
Switzerland 1 (7%) - 1 (5%) -
United States - - 1 (5%) -
  Oregon - - 1 (5%) -
Domestic 9 (64%) - 13 (68%) -
Cross-border 5 (36%) - 6 (32%) -
Total 14 - 19 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 7 (50%) - 10 (53%) -
Growth Capital 5 (36%) - 5 (26%) -
Consolidation 1 (7%) - 2 (11%) -
Secondary Buyout 1 (7%) - 1 (5%) -
Venture - - 1 (5%) -
Total 14 - 19 -

Exits by Deal Type

Type Total # Value
Trade Sale 5 (71%) -
Trade Sale - Public Company 2 (29%) 169M (100%)
Total 7 $169M

Top M&A Advisors

Financial Deals
KPMG Corporate Finance
1
Lincoln International
1
Aon Securities
1
Legal Deals
Pinsent Masons
2
Charles Russell Speechlys
2
Trowers & Hamlins
1

Deal Values

sell # Total
$100M to $1B 1 $102M
< $100M 1 $68M
TOTAL $169M
Largest ZONARE Medical Systems, Inc.
$102M (2013-07-17)

M&A Connections

Deals
Acquired from
Investor(s)
5%
1 (5%)
Exited to
Strategic(s)
100%
7 (100%)

FAQ

When was Apposite Capital founded?

Apposite Capital was founded in 2006.

What type of investor is Apposite Capital?

Apposite Capital is a private equity firm.

Where is Apposite Capital headquartered?

Apposite Capital is headquartered in London, United Kingdom.

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.